These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 29800485)

  • 21. Autologous platelet-rich plasma for assisted reproduction.
    Vaidakis D; Papapanou M; Siristatidis CS
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013875. PubMed ID: 38682756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced sperm selection techniques for assisted reproduction.
    Lepine S; McDowell S; Searle LM; Kroon B; Glujovsky D; Yazdani A
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD010461. PubMed ID: 31425620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection.
    Brown J; Daya S; Matson P
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004378. PubMed ID: 27976360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles.
    Boomsma CM; Kamath MS; Keay SD; Macklon NS
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD005996. PubMed ID: 35771604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes.
    Glujovsky D; Pesce R; Sueldo C; Quinteiro Retamar AM; Hart RJ; Ciapponi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006359. PubMed ID: 33112418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antioxidants for male subfertility.
    Smits RM; Mackenzie-Proctor R; Yazdani A; Stankiewicz MT; Jordan V; Showell MG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD007411. PubMed ID: 30866036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.
    Melo P; Georgiou EX; Johnson N; van Voorst SF; Strandell A; Mol BWJ; Becker C; Granne IE
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002125. PubMed ID: 33091963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection.
    Kamath MS; Mascarenhas M; Kirubakaran R; Bhattacharya S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD003416. PubMed ID: 32827168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular flushing during oocyte retrieval in assisted reproductive techniques.
    Georgiou EX; Melo P; Brown J; Granne IE
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD004634. PubMed ID: 29697138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial injury in women undergoing in vitro fertilisation (IVF).
    Lensen SF; Armstrong S; Gibreel A; Nastri CO; Raine-Fenning N; Martins WP
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD009517. PubMed ID: 34110001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening hysteroscopy in subfertile women and women undergoing assisted reproduction.
    Kamath MS; Bosteels J; D'Hooghe TM; Seshadri S; Weyers S; Mol BWJ; Broekmans FJ; Sunkara SK
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012856. PubMed ID: 30991443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidants for male subfertility.
    de Ligny W; Smits RM; Mackenzie-Proctor R; Jordan V; Fleischer K; de Bruin JP; Showell MG
    Cochrane Database Syst Rev; 2022 May; 5(5):CD007411. PubMed ID: 35506389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid in embryo transfer media for assisted reproductive technologies.
    Heymann D; Vidal L; Or Y; Shoham Z
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD007421. PubMed ID: 32876946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso NN; Hassan R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone for in vitro fertilisation (IVF).
    Sood A; Mohiyiddeen G; Ahmad G; Fitzgerald C; Watson A; Mohiyiddeen L
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD000099. PubMed ID: 34808697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antioxidants for male subfertility.
    Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
    Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.
    Craciunas L; Tsampras N; Coomarasamy A; Raine-Fenning N
    Cochrane Database Syst Rev; 2016 May; (5):CD011537. PubMed ID: 27195724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    Tang H; Mourad S; Zhai SD; Hart RJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008605. PubMed ID: 27901279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.